Home › Funds › JPMorgan Chase & Co › INTS
JPMorgan Chase & Co position in INTS
INTENSITY THERAPEUTICS INC · Health Care
Latest position (Q1 2025)15 sh
Reported value held$30
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1 | $4 | New |
| Q4 2023 | 40 | $343 | Add |
| Q1 2024 | 8.87K | $46.12K | Add |
| Q2 2024 | 18 | $88 | Reduce |
| Q3 2024 | 17 | $65 | Reduce |
| Q4 2024 | 17 | $30 | Hold |
| Q1 2025 | 15 | $30 | Reduce |
| Q1 2025 | 15 | $30 | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding INTS
- Vanguard Group 649.08K sh · $266.12K · Q4 2025
- Geode Capital Management 22.79K sh · $93.43K · Q2 2026
- Morgan Stanley 20 sh · $82 · Q2 2026
- UBS Group AG 1 sh · $4 · Q2 2026